United BioSource Corporation - Center for Health Outcomes Research

United BioSource Corporation - Center for Health Outcomes Research
Share

From the time humans begin taking an investigational new drug, pharmacovigilance measures play a critical role in every phase of a product’s lifecycle. However, understanding pharmacovigilance requirements can be daunting even for seasoned industry pros. This overview will answer all the questions you ever wanted to know about pharmacovigilance, ...

The 31st International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE) will bring healthcare professionals together August 23 – 26 in Boston. This meeting is a great chance to discuss the trends in the industry with an eye on patient safety. We’ve seen tighter regulations and cost containment measures driving the demand for ...

There is increasing demand from payers to gather evidence on the safety of medications used in the general population post-commercialization. Conducting a literature review involving critical appraisal is essential to better understand the research topic and assess the validity of the research findings. A literature review entitled “Long-acting ...

Moving pharmaceutical products from development into commercialization is no small feat. Doing so for a rare disease and improving speed to therapy is even more challenging — but because of UBC’s unique solutions for the entire drug lifecycle, it’s a challenge that we can take on. Watch the video below to learn what an integrated program model can ...

THE LAB unites innovative talent, tools, and technology from across the Express Scripts family of companies — UBC, the PBM, and Accredo Specialty Pharmacy — in service of a single goal: To drive next-generation solutions that solve the most pressing problems in healthcare and pharmacy. I have the privilege of hosting LAB visits and working ...

Stop by booth 1206/1208 at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 20th annual meeting May 16 – 20 in Philadelphia to meet our scientific staff. Members of our Value Demonstration and Database Analytics Automation teams will be available throughout the conference to meet customers and talk about our real-world ...

The new Disclosure Code from the European Federation of Pharmaceutical Industries and Associations (EFPIA) went into effect on 1 January 2015. Manufacturers should have finalised their plans by now in order to collect the requisite data and avoid potential violations. EFPIA Disclosure Code Basics
The new EFPIA code requires reporting of transfers ...

This week healthcare organizations around the globe have been taking part in Patient Safety Awareness Week by focusing on the importance of healthcare safety. Following the week’s theme, “United in Safety,” UBC recognizes that delivering safe care to patients is an important role for each of us – from frontline staff to the executive suite.UBC ...

Rare diseases are a hot topic in healthcare today. Google “rare disease” and you’ll find hundreds of news stories about the research efforts of many companies and advocacy groups. Interestingly, 40% of novel drug approvals by the FDA in 2014 were indicated for rare conditions. Getting these drugs into the hands of patients and providing them with ...

This year is shaping up to be another exciting one for the UBC team. With nearly 50 conferences already booked for the year, our thought leaders are looking forward to learning, networking, and presenting their work at a host of industry events. Here is a sampling of our first quarter events. We hope to see you in person very soon! DIA ...